These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19535825)

  • 1. Together we care: new challenges for global haemophilia treatment centers.
    Franchini M; Lippi G
    Indian J Med Res; 2009 Apr; 129(4):345-7. PubMed ID: 19535825
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemophilia care in Europe: a survey of 19 countries.
    O'Mahony B; Noone D; Giangrande PL; Prihodova L
    Haemophilia; 2011 Jan; 17(1):35-40. PubMed ID: 20722746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: 'Haemophilia: new challenges and winning directions'.
    Santagostino E; Franchini M
    Haemophilia; 2010 Jan; 16 Suppl 1():1. PubMed ID: 20059561
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Home therapy for haemophilia.
    Br Med J; 1975 Feb; 1(5955):417. PubMed ID: 1115959
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of pool cryoglobulin factor 8 concentrate in the management of haemophilia.
    O'Brien JR
    Proc R Soc Med; 1967 Mar; 60(3):243-4. PubMed ID: 6020147
    [No Abstract]   [Full Text] [Related]  

  • 6. The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update.
    Lusher JM; Roth DA
    Haemophilia; 2005 May; 11(3):292-3. PubMed ID: 15876278
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Factor VIII replacement in the treatment of haemophilia A--a simple illustration of a need-supply-demand spiral.
    Spencely M; Cash JD
    Br J Prev Soc Med; 1974 Feb; 28(1):71. PubMed ID: 4816606
    [No Abstract]   [Full Text] [Related]  

  • 8. Cumulative analysis of inhibitor formation in patients with haemophilia A treated with sucrose-formulated recombinant factor VIII.
    Bajwa N; Enriquez MM; Gorina E; Lemm G
    Haemophilia; 2009 Mar; 15(2):597-600. PubMed ID: 19187195
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience of tailoring prophylaxis using factor VIII pharmacokinetic parameters estimated with myPKFiT
    Álvarez-Román MT; Fernandez-Bello I; de la Corte-Rodríguez H; Hernández-Moreno AL; Martín-Salces M; Butta-Coll N; Rivas-Pollmar MI; Rivas-Muñoz S; Jiménez-Yuste V
    Haemophilia; 2017 Jan; 23(1):e50-e54. PubMed ID: 28074560
    [No Abstract]   [Full Text] [Related]  

  • 10. Home infusions for haemophilia.
    S Afr Med J; 1973 Jan; 47(1):1. PubMed ID: 4686244
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressing towards optimal management of haemophilia A patients with inhibitors. Foreword.
    Tarantino MD
    Haemophilia; 2013 Jan; 19 Suppl 1():1. PubMed ID: 23278992
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of haemophilia A with anti-haemophilic factor.
    Sherlock M
    Med J Aust; 1966 Mar; 1(11):445-6. PubMed ID: 5909130
    [No Abstract]   [Full Text] [Related]  

  • 13. Cryoprecipitate in the management of haemophilia in Kenya.
    Taylor JR; Ahluwalia NS; Morrison CJ; Kaviti JN; Cardwell CL
    East Afr Med J; 1969 Feb; 46(2):121-8. PubMed ID: 5798053
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of factor VIII replacement during open heart surgery in a patient with haemophilia A.
    Stine KC; Becton DL
    Haemophilia; 2006 Jul; 12(4):435-6. PubMed ID: 16834747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrated preparations of Factor 8 (antihaemophilic globulin) in the management of haemophilia A and von Willebrand's disease.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Med J Aust; 1967 Sep; 2(11):481-5. PubMed ID: 5299300
    [No Abstract]   [Full Text] [Related]  

  • 16. Defining adherence to prophylaxis in haemophilia.
    Schrijvers LH; Cnossen MH; Beijlevelt-Van der Zande M; Peters M; Schuurmans MJ; Fischer K
    Haemophilia; 2016 Jul; 22(4):e311-4. PubMed ID: 27227699
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to review the way we estimate access to haemophilia concentrates worldwide.
    Farrugia A
    Haemophilia; 2017 May; 23(3):e235-e237. PubMed ID: 28520206
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylaxis in patients with haemophilia: introduction.
    Chambost H
    Haemophilia; 2010 Mar; 16 Suppl 2():1-3. PubMed ID: 20132331
    [No Abstract]   [Full Text] [Related]  

  • 19. Haematology clinic: Haemophilia A.
    Mannucci PM; Franchini M
    Hematology; 2014 Apr; 19(3):181-2. PubMed ID: 24649801
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of factor VIII after inhibitor clearance in patients with moderate haemophilia A: a case series.
    Tran DQ; Harvey RD; Meeks SL; Chapman R; Kempton CL
    Haemophilia; 2014 Jul; 20(4):e344-6. PubMed ID: 24750497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.